Using calmagite as the compleximetric agent in spectrophotometric measurements of magnesium in serum involves a nonspecific matrix effect, which may bias results by as much as 25 to 30% if aqueous standards are used in serum assays.
adding Empigen BB shifted the absorbance mRvimum of the blank, but not of the magnesium.-calmagite complex, thus increasing the signal-to-noise ratio. Furthermore, the positive intercepts of dilution curves for samples without Empigen BB became zero with Empigen BB, indicating elimination of the matrix effect. (2) optimized their method by using a more concentrated calinagite reagent, thereby extending linearity of standard curves up to 5 mmol/L. Our standard curve is linear only between 0 and 2 mmol/L, but we optimized our method for small sample volumes (10 L) and low magnesium concentrations (<1 mmol/L). We optimized the method for final concentration of Empigen BB (1.5 g/L), time of incubation (<1 h), pH (11.8), temperature (20 to 25#{176}C), measurement wavelength (529 rim), sample volume (10 pL), and order of reagent addition (to 5 pL of Empigen BB add 500 pL of color reagent and 500 pL of base reagent, then 10 uL of sample, standard, or demetallized water). With Empigen BB included, the assay performed as follows. Within physiological values for magnesium, the within-day CV ranged from 2.9 to 3.9%, and the betweenday CV ranged from 3.1 to 4.3%. Analytical recovery of added magnesium averaged 98.4%. Change in ionic milieu (up to twice the normal concentration of important ions) did not change analytical outcome. Results agree well with those determined by atomic absorbance spectrophotometry (p = 0.6, by Student's paired t-test).
Abernethy and Fowler
Problems with Blood Gas Analysis Revisited, G. E.
Wieringa (Dept. of Chem. Pathol., North Manchester Gen. Hosp., Crumpsall, Manchester M8 6RB, U.K.)
The use of pre-heparunized syringes for blood gas analysis representsboth a rapid and convenient blood-collection method. One type of collection syringe widely used in both U.K. and U.S.A. is the Concord Pulsator (Concord Laboratories, Folkstone, U.K.), which self-fills under arterial pressure but contains 0.5 mL of sodium heparin solution, any excess of which must be expelled before the sampling. The danger of not expelling excess heparin or not collecting the prescribed 3 mL of blood is illustrated in the following example. Arterial blood was collected by Pulsator and simultaneously a specimen was collected by venipuncture, for electrolyte determinations.
Both were analyzed within 20 mm of collection. The measured total CO2 was 31 mmol/ L, and the calculated total CO2 (from pH and pco2) was 22 mmol/L. On seeing the total CO2 (TOO2) discrepancy, I found that less than 2 mL of blood had been collected by the Pulsator, although the phlebotomist assured the laboratory that excess heparin had been expelled. Discrepancies of up to 12 mmol/L in TOO2 had previously been documented but cross checks between analyzers indicated no laboratory error. In virtually all these examples heparin was not fully expelled before sampling and (or) less than 3 mL of whole blood was collected.
These observations are not new (1, 2) but were more commonly seen when heparin solution had to be added to a syringe. In discussions, the company has always been helpful and its representatives assure us that errors are minimized if instructions are followed. They have recently introduced a new syringe (Concord Micropulse) with less dead space and with instructions on the side to "expel excess heparin." Further instructions are also available from the company as well as a poster; we urge all hospital supply departments who issue the syringe to obtain these. During development of air/acetylene flame atomic absorption method for assay of serum magnesium in a Varian P/L AA975 instrument, we noted sporadic episodes of calibration instability and decreasing absorbance readings for samples. Troubleshooting provided no evidence of burner blockage. The cause of the interference was traced to production of a metastable aqueous foam (1). In the method under development we initially used a 100-fold dilution of serum or plasma in a 10 g/L solution of nitric acid (from 70% HNO3; Ajax Chemicals, Sydney, Australia) containing 2 g of lanthanum chloride per liter (from 100 g/L LaCl3; BDH Chemicals, Sydney, Australia). The high sample dilution should have yielded a stable and interferencefree analysis. It was therefore annoying to encounter unstable and imprecise analyses during the method development. After approximately 3 mL of diluted sample had been aspirated, the instrument's spray chamber became filled with a stable foam, which effectively blocked gas-and sample-flows to the burner, leading to decreased absorbance readings.
The problem was rectified by mixing butan-1-ol (BDH Chemicals) with the sample diluent at a concentration of 50 mL/L. Changing the composition of the mixture away from CCJT!IFUOIT100 (1600 U 9. 15 tIn.
4CC)
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LIQUID SCOITILLITIOU CO!UTEI the critical concentrations required to produce the metastable foam would also have remedied the problem, but would have affected analytical sensitivity. How frequently may this problem affect flame atomic absorption analysis? Imprecise and drifting absorbance readings are usually attributed to analysis of samples high in solids, which block the burner slots, or to nebulizer failures. The possibility of blocking the spray chamber would seem remote because of its large interior volume. Additionally, to identifr this problem, one would have to shut down the flame during an analytical run and disassemble the spray chamber for inspection. Thus the presence of an interfering foam would probably pass unnoticed.
Butanol has been used in the past (2) as a signal enhancer; this enhancing effect may have been partly due to the inhibition of foam formation. Overly noisy magnesium assays in protein-containing solutions of lanthanum chloride ( In our laboratory we modified an enzymatic creatinine kit (Boehringer Mannheim, for use in the Hitachi 705) to measure creatine in serum. In this enzymatic creatinine PAP (p-aniinophenazone) kit, creatinine is enzymatically converted by creatininase (EC 3.5.2.10) to creatine, which is then measured by a sequence of three enzymatic steps. For measurement of creatine, we omit the creatininase, which is supplied in the kit in separate tablets, and make use of the remaining reaction sequence: red benzoquinone-imine dye
To obviate possible interferences, one must include a sample blank, which consists of the reagent plus added pchloromercuribenzoic acid (3.6 mg/10 mL of reagent), to inactivate the enzymes.
For the creatine standard we use aqueous creatine monohydrate. The standard curve for our method is linear to at least 250 moI/L.
Comparison of the results by our method (y) with those by the method in which creatine is converted chemically to creatinine and assayed by a standard Jaffecreatinine method (x) gave the following linear regression equation: y = 0.97x + 1.4; n = 36; r2 = 0.973.
We found less day-to-day variation by our method (CV 6.1% at 30.3 anol/L, n = 19) than for the Jaffe method (CV 15.4% at 40.7 pmoIfL, n = 19). Analytical recovery of creatine added to serum was 96.1%. Values for creatine are slightly increased (4-10%) by hemolytic sera. The method is not suitable for use with lipemic or icteric sera. We compared the classical Bligh/Dyer extraction procedure (first with chloroform/methanol, followed by separation in chloroform/water) and a much simpler extraction with acetonitrile.
Simple Method for
The figure below shows schematically the steps we used in the two methods to extract vitamin D metabolites from samples of rat-kidney homogenate and dog-tibia perfusate. Radioactivity recovered was used as a measure of the extraction efficiency.
Analytical recovery obtained for [3H]25(OH)D3 extraction from kidney homogenate was 75.2 ± 5.6 by the BlighfDyer procedure vs 81.3 ± 4.1 with acetonitrile (P <0.005, m = 6). The recovery for perfusate samples was 85.1 ± 8.5 and 98.6 ± 3.3 by the Bligh/Dyer and acetonitrile procedures, respectively (P <0.0025, n = 6). Therefore, the extraction was better with acetonitrile than with the Bligh/Dyer procedure.
Comparing recovery of [3H]1,25(OH)2D3 in kidney homogenate by the two methods, we found no significant differences (82.5 ± 5.6 by Bligh/Dyer and 84.0 ± 3.2 by acetonitrile, n = 18), but the precision was better with acetonitrile, and the procedure is easier and quicker.
Thus we suggest that acetonitrile be used to extract vitamin D metabolites from biological samples. 
